Cannabis Report
Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

If anybody understands the extra $2M investment identified

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
kabunushi Member Profile
 
Followed By 22
Posts 2,147
Boards Moderated 0
Alias Born 01/17/03
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/28/2018 5:23:29 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/28/2018 4:12:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/18/2018 5:16:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/1/2018 4:34:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/31/2018 5:01:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/31/2018 7:03:23 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/21/2018 4:44:29 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/16/2018 5:06:32 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/16/2018 4:42:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2018 5:26:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/2/2018 3:52:43 PM
Traders News Source Issues Research Reports on ANDI, FUSZ, RNVA and NWBO InvestorsHub NewsWire - 4/19/2018 8:00:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 4/17/2018 5:11:43 PM
Revised Proxy Soliciting Materials (definitive) (defr14a) Edgar (US Regulatory) - 4/12/2018 5:26:20 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/9/2018 4:15:48 PM
Proxy Soliciting Materials (revised) (prer14a) Edgar (US Regulatory) - 4/4/2018 5:19:57 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 4/3/2018 6:07:43 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 3/26/2018 5:18:11 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 3/26/2018 5:12:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/22/2018 4:41:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/20/2018 5:11:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/15/2018 5:21:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/7/2018 4:06:26 PM
StereoVision (SVSN) $420 million in Sales from $1,000 Acre Hemp Farm Lease InvestorsHub NewsWire - 3/6/2018 6:47:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/2/2018 5:27:04 PM
kabunushi   Thursday, 12/07/17 05:15:53 PM
Re: None
Post # of 182838 
If anybody understands the extra $2M investment identified in item 3.02 of the latest 8-k for the offering, please help me understand the pricing. It's a complicated mix of reducing some 6M warrants from .26 to .22, issuing 5M new warrants at .22 and issuing 120k new preferred warrants. Given that the preferred is worth $1.70, that part is only about $200k. The .04 warrant strike reduction for 6M is only worth another some $250k, and the 5M or so new warrants at .22 seem like they'd be worth well under .22 - even pricing those at .22 (and they gotta be worth far less than that) would still net out to value of under $1.5M for $2M cash. What am I missing, if anybody is curious enough to try to figure this mystery out?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist